Verizon's strong Q2 earnings, improved dividend safety, & deleveraging efforts boost investor confidence. Read more on why VZ ...

Markus joined AT&T in 2020, having held technology leadership and transformation positions for leading media companies ...

Verizon trades at just 9x earnings with a 6.3% yield, poised for upside from AI, 5G, and dividend growth potential. Find out ...

By studying 100 brand implementations of gen AI, researchers have discovered four archetypes for how companies are using the technology strategically. Bold innovators seek to reshape their markets ...

The CMO role has never held more potential to shape the future. But we can’t lead with buzzwords or bravado. We have to lead ...

5G leadership that sets the pace: Verizon’s 5G Ultra Wideband continues to raise the bar, offering blazing-fast speeds and ultra-low latency for streaming, gaming and remote work. With dedicated ...

Q2 2025 Earnings Call Transcript July 21, 2025 Verizon Communications Inc. beats earnings expectations. Reported EPS is $1.22 ...

Wireless competitive intensity has increased recently, but we expect Verizon and its two primary wireless rivals, T-Mobile and AT&T, to compete rationally in the coming years, allowing each to ...

Verizon Communications (NYSE:VZ) boosted the lower end of its full-year adjusted earnings per share guidance after its second ...

Brand Engagement Network Inc. (BEN) (NASDAQ: BNAI), a global provider of AI-powered customer engagement solutions, today announced that Janine Grasso has been appointed Interim Chief Executive Officer ...

Kenvue Inc. said Chief Executive Officer Thibaut Mongon will leave the company as it continues to revamp the maker of Tylenol, Neutrogena and Listerine brands.

Kenvue, the Johnson & Johnson spinoff that makes Tylenol and Benadryl, named director Kirk Perry as interim chief executive officer as Thibaut Mongon departs the company.